| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |